Venter: Synthetic cells will revolutionize vax development

J. Craig Venter told lawmakers yesterday that the ability to create synthetic genes could revolutionize the development of new vaccines. Using the new technology that he's been pioneering, Venter says that flu vaccine candidates could be constructed within 24 hours of an outbreak. Researchers now require about three months to do the work. Synthetic cells provide researchers with the "software of life," Venter told Congress. Report

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.